MVA-member, BioInnovation Institute, will award an extra DKK 35M to start-ups joining their Creation House program
There is good news for early-stage Nordic start-ups in medtech, biotech and pharma. In 2019, BioInnovation Institute will award an extra DKK 35M which will amount to a total of DKK 150M awarded to life science projects since the inauguration of the institute in November 2018.
“After less than a year it is clear to us that there are more high-quality projects and promising early-stage start-ups than we can support. There is not only a need for further investments but also for the business development BII provides in terms of our strong, global networks, mentors, investor traction and infrastructure,” says CEO Jens Nielsen, BioInnovation Institute in a press release issued this morning.
The extra DKK 35M will be awarded to start-ups joining the Creation House program.